Find trials
Search tips

Registry of Angiovac Procedures In Detail Outcomes Database (RAPID)

Overview

About this study

The purpose of the RAPID registry is to collect information on the Angiovac procedure and Angiovac device used in the removal of fresh, soft thrombi or emboli during extracorporeal bypass for up to 6 hours.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All patients in whom the Angiovac device was placed into the body for removal of fresh, soft thrombi or emboli during extracorporeal bypass for up to 6 hours.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Haraldur Bjarnason, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20306549

Mayo Clinic Footer